Literature DB >> 576532

Vasoactive intestinal peptide (VIP): variation of the jejuno-ileal content in the developing rat as measured by radioreceptorassay.

M Laburthe, D Bataille, G Rosselin.   

Abstract

This study was undertaken to investigate the variations of the Vasoactive Intestinal Peptide (VIP) content of rat jejuno-ileum (JI) with age. VIP was measured by its ability to inhibit competitively the binding of [125I]pork VIP (pVIP) to rat liver plasma membranes. The radio receptor assay was sensitive to 0.5 ng/ml. VIP fragments 1-6, 14-28 and 18-28 exhibited no cross reaction with [125I]pVIP. Glucagon had no effect and secretin was about 100 times less effective than pVIP. Rat VIP was extracted from JI by 0.5 M acetic acid and partially purified by adsorption on silicate. The effect of JI extracts in inhibiting the binding of [125I]pVIP paralleled that of pVIP used as standard. The VIP content of JI showed a 340-fold increase between day 21 post coitum (p.c.): 41 +/- 4 ng/JI and day 63 post partum (p. p.): 14 110 +/- 954 ng/JI. On a gut weight basis, VIP increased slightly from day 21 p. c. (591 +/- 51 ng/g of JI) to day 14 p. p. (906 +/- 109 ng/g of JI) and then increased more sharply (day 21 p. p.: 1508 +/- 222 ng/g of JI) until day 63 p. p. (2672 +/- 207 ng/g of JI). The VIP content seemed to reach a plateau after 2 months. A similar pattern was observed when the results were expressed per mg of JI protein. It is speculated that the rise in VIP content is related to the role of this peptide in the regulation of the gastro-intestinal function and/or the distribution of fuels in the organism.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 576532     DOI: 10.1530/acta.0.0840588

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  10 in total

1.  Vasoactive intestinal peptide receptors in rat liver after partial hepatectomy.

Authors:  L G Guijarro; A Couvineau; M S Rodriguez-Pena; M G Juarranz; N Rodriguez-Henche; E Arilla; M Laburthe; J C Prieto
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

2.  Vasoactive intestinal peptide: a potent stimulator of adenosine 3':5'-cyclic monophosphate accumulation in gut carcinoma cell lines in culture.

Authors:  M Laburthe; M Rousset; C Boissard; G Chevalier; A Zweibaum; G Rosselin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

3.  VIP receptors and control of short circuit current in the human intestinal clonal cell line Cl.19A.

Authors:  C Rouyer-Fessard; C Augeron; E Grasset; J J Maoret; C L Laboisse; M Laburthe
Journal:  Experientia       Date:  1989-12-01

4.  Role of phospholipids in the binding activity of vasoactive intestinal peptide receptors.

Authors:  A Sarrieau; N Boige; M Laburthe
Journal:  Experientia       Date:  1985-05-15

5.  Vasoactive intestinal polypeptide: specific binding to rat brain membranes.

Authors:  D P Taylor; C B Pert
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

Review 6.  Pathophysiology of gastrointestinal hormones. Implications for paediatrics.

Authors:  I Henrichs; W M Teller
Journal:  Eur J Pediatr       Date:  1980-10       Impact factor: 3.183

7.  The rat liver vasoactive intestinal peptide binding site. Molecular characterization by covalent cross-linking and evidence for differences from the intestinal receptor.

Authors:  A Couvineau; M Laburthe
Journal:  Biochem J       Date:  1985-01-15       Impact factor: 3.857

8.  A new bioassay of VIP: results in watery diarrhoea syndrome.

Authors:  M C Laburthe; C M Dupont; J D Besson; M Rousset; G E Rosselin
Journal:  Gut       Date:  1980-07       Impact factor: 23.059

9.  Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.

Authors:  A Couvineau; M Rousset; M Laburthe
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

10.  Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase.

Authors:  J C Prieto; J M Guerrero; C de Miguel; R Goberna
Journal:  Mol Cell Biochem       Date:  1981-07       Impact factor: 3.396

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.